Exquisite Sensitivity of TP53 Mutant and Basal Breast Cancers to a Dose-Dense Epirubicin−Cyclophosphamide Regimen-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exquisite Sensitivity of TP53 Mutant and Basal Breast Cancers to a Dose-Dense Epirubicin−Cyclophosphamide Regimen

Published:2007-03-20 Issue:3 Volume:4 Page:e90
ISSN:1549-1676
Container-title:PLoS Medicine
language:en
Short-container-title:PLoS Med

Author:

Bertheau Philippe,Turpin Elisabeth,Rickman David S,Espié Marc,de Reyniès Aurélien,Feugeas Jean-Paul,Plassa Louis-François,Soliman Hany,Varna Mariana,de Roquancourt Anne,Lehmann-Che Jacqueline,Beuzard Yves,Marty Michel,Misset Jean-Louis,Janin Anne,de Thé Hugues

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference44 articles.

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive gene expression profile for adjuvant taxane benefit in breast cancer in the MATADOR trial;iScience;2024-08

2. Outcomes of De Novo Oligometastatic Breast Cancer Treated With Surgery of Primary and Metastasis Directed Radiotherapy;American Journal of Clinical Oncology;2024-07-04

3. Suppression of Bcl3 Disrupts Viability of Breast Cancer Cells through Both p53-Dependent and p53-Independent Mechanisms via Loss of NF-κB Signalling;Biomedicines;2024-01-10

4. Exploring SPK98 for the Selective Sensitization of ATM- or P53-Deficient Cancer Cells;ACS Omega;2023-01-30

5. Cellular senescence in cancer: clinical detection and prognostic implications;Journal of Experimental & Clinical Cancer Research;2022-12-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP